CLINICAL USE OF INTERMEDIATE TO HIGH-DOSE OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA

被引：2

作者：

TAKASHIMA, Y ^{[1
]}

机构：

[1] MEIJO HOSP,PEDIAT CLIN,FEDERAT NATL PUBL SERV PERSONNEL MUTUAL AID ASSOC,NAKA KU,NAGOYA 460,JAPAN

来源：

关键词：

D O I：

10.1002/j.1552-4604.1988.tb03158.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：356 / 362

页数：7

共 27 条

[1] AOSHIMA M, 1976, CANCER RES, V36, P2726
[2] AOSHIMA M, 1977, CANCER RES, V37, P2481
[3] STUDIES OF ENZYMATIC DEAMINATION OF CYTOSINE ARABINOSIDE .1. ENZYME DISTRIBUTION AND SPECIES SPECIFICITY
CAMIENER, GW
SMITH, CG
[J]. BIOCHEMICAL PHARMACOLOGY, 1965, 14 (10) : 1405 - &
[4] EARLY AP, 1982, CANCER RES, V42, P1587
[5] FUJITA H, 1983, CHEMOTHERAPY, V31, P723
[6] HO DHW, 1971, CLIN PHARMACOL THER, V12, P944
[7] HO DHW, 1977, CLIN PHARMACOL THER, V22, P371
[8] HOSHI A, 1971, GANN, V62, P145
[9] KIMURA K, 1985, CANCER, V56, P1913, DOI 10.1002/1097-0142(19851015)56:8<1913::AID-CNCR2820560803>3.0.CO
[10] 2-W